VISIPAQUE

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Japan, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug VISIPAQUE contains one active pharmaceutical ingredient (API):

1 Iodixanol UNII HW8W27HTXX - IODIXANOL

Read about Iodixanol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VISIPAQUE Solution for injection	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V08AB09	Iodixanol	V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
Discover more medicines within V08AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 541612090001004, 541612090001114, 541612090001204, 541612090001704, 541612090001804, 541616070002203
Country: CA	Health Products and Food Branch	Identifier(s): 02145766, 02145774
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5005-MEE-0320
Country: EE	Ravimiamet	Identifier(s): 1038114, 1038125, 1079344, 1079355, 1079366, 1079377, 1079388, 1079399, 1140905, 1140927, 1140972, 1140983, 1141029, 1141030, 1141074, 1141108, 1141153, 1141164, 1141175, 1141186
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60636, 60637
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 019121, 019132, 582882, 583401, 583450, 583518, 583609, 583708
Country: FR	Base de données publique des médicaments	Identifier(s): 60567418, 60960777
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 377352, 398066, 398067, 80822, 80823, 80824, 80825, 80828
Country: HK	Department of Health Drug Office	Identifier(s): 43490, 43491
Country: JP	医薬品医療機器総合機構	Identifier(s): 7219420A1031, 7219420A2038, 7219420A3034, 7219420A4030, 7219420A5037
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010525, 1010526, 1010527, 1010528, 1011301, 1011302, 1011303, 1011304, 1021975, 1021976, 1021977, 1021979, 1021980, 1021981, 1026459, 1026460, 1069917, 1069918, 1069919, 1069920, 1078673, 1078674, 1078675, 1078676, 1078677, 1089024, 1089025, 1089026, 1089027
Country: MT	Medicines Authority	Identifier(s): MA023/00201, MA023/00202
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7154, 7159
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100093688, 100195147
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W12012001, W12012002, W12012003, W12012004, W12012005, W12012007, W12012008, W12013001, W12013002, W12013003, W12013004, W12013005, W12013006, W12013007
Country: SG	Health Sciences Authority	Identifier(s): 08882P, 08883P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 2453041, 2453042, 2453043
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699688772143, 8699688772150, 8699688772242, 8699688772259, 8699688772266
Country: US	FDA, National Drug Code	Identifier(s): 0407-2222, 0407-2223
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/28/0171, 31/28/0172, 31/28/0175, 31/28/0176, 31/28/0177, 36/28/0134, 36/28/0136